The Motley Fool

Key Data Points

Primary metrics and data points about ImmunoGen.
Current Price: $10.89
Prev Close: $10.04
Open: $9.83
Bid: $10.50
Ask: $14.68
Day's Range: $9.65 - $10.96
52wk Range: $5.34 - $19.43
Volume: 1,695,118
Avg Vol 1,624,367
Market Cap: $947M
P/E (ttm): -14.14
EPS (ttm): ($0.71)
Div & Yield: $0.00 (0.0%)

News and Headlines

Latest news about ImmunoGen from

Business Summary

Industry, sector and description for ImmunoGen.

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

IMGN vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about ImmunoGen.
CAPS Rating 3 out of 5
331 Outperform
23 Underperform
CAPS All Stars
68 Outperform
4 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Dan Junius, CEO

78% Approve

Based on 10 Ratings

More Details for ImmunoGenJobs

Powered by

More Details about ImmunoGen

Primary metrics and data points about ImmunoGen.